Analysis of tractable allosteric sites in G protein-coupled receptors.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 04 2019
Historique:
received: 22 01 2019
accepted: 28 03 2019
entrez: 18 4 2019
pubmed: 18 4 2019
medline: 21 10 2020
Statut: epublish

Résumé

Allosteric modulation of G protein-coupled receptors represent a promising mechanism of pharmacological intervention. Dramatic developments witnessed in the structural biology of membrane proteins continue to reveal that the binding sites of allosteric modulators are widely distributed, including along protein surfaces. Here we restrict consideration to intrahelical and intracellular sites together with allosteric conformational locks, and show that the protein mapping tools FTMap and FTSite identify 83% and 88% of such experimentally confirmed allosteric sites within the three strongest sites found. The methods were also able to find partially hidden allosteric sites that were not fully formed in X-ray structures crystallized in the absence of allosteric ligands. These results confirm that the intrahelical sites capable of binding druglike allosteric modulators are among the strongest ligand recognition sites in a large fraction of GPCRs and suggest that both FTMap and FTSite are useful tools for identifying allosteric sites and to aid in the design of such compounds in a range of GPCR targets.

Identifiants

pubmed: 30992500
doi: 10.1038/s41598-019-42618-8
pii: 10.1038/s41598-019-42618-8
pmc: PMC6467999
doi:

Substances chimiques

Ligands 0
Receptors, G-Protein-Coupled 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6180

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM118078
Pays : United States

Références

Nat Commun. 2014 Jul 10;5:4355
pubmed: 25008467
J Phys Chem B. 2016 Aug 25;120(33):8685-95
pubmed: 27258368
Bioinformatics. 2003 Feb 12;19(3):429-30
pubmed: 12584135
Trends Cell Biol. 2018 Aug;28(8):591-594
pubmed: 29945844
Nat Rev Drug Discov. 2002 Mar;1(3):198-210
pubmed: 12120504
Nature. 2014 Jul 31;511(7511):557-62
pubmed: 25042998
Methods Mol Biol. 2018;1705:297-319
pubmed: 29188568
J Med Chem. 2006 Aug 10;49(16):4992-5000
pubmed: 16884311
Nature. 2017 Jun 8;546(7657):312-315
pubmed: 28514449
J Chem Inf Model. 2012 Aug 27;52(8):2236-44
pubmed: 22770357
J Chem Inf Model. 2009 Feb;49(2):377-89
pubmed: 19434839
Nature. 2016 Dec 15;540(7633):462-465
pubmed: 27926729
Science. 2014 Apr 4;344(6179):58-64
pubmed: 24603153
Curr Med Chem. 2007;14(28):3027-34
pubmed: 18220738
Biochem J. 2014 Mar 1;458(2):387-94
pubmed: 24313835
Nature. 2018 Jul;559(7712):45-53
pubmed: 29973731
Biophys J. 2009 Nov 18;97(10):2846-53
pubmed: 19917240
Nature. 2017 Jun 8;546(7657):259-264
pubmed: 28514451
J Biol Chem. 2015 Aug 7;290(32):19478-88
pubmed: 26100627
Proteins. 2004 Nov 15;57(3):433-43
pubmed: 15382234
Nature. 2016 Jul 28;535(7613):517-522
pubmed: 27437577
Nucleic Acids Res. 2018 Jul 2;46(W1):W451-W458
pubmed: 29757429
Annu Rev Pharmacol Toxicol. 2014;54:165-84
pubmed: 24111540
Trends Biochem Sci. 2010 Sep;35(9):471-5
pubmed: 20382026
Annu Rep Med Chem. 2012;47:441-457
pubmed: 26962268
Science. 2010 Nov 19;330(6007):1066-71
pubmed: 20929726
Structure. 2014 Nov 4;22(11):1657-64
pubmed: 25450769
Nature. 2013 Jul 25;499(7459):438-43
pubmed: 23863939
Nature. 2016 Dec 15;540(7633):458-461
pubmed: 27926736
BMC Bioinformatics. 2009 Jun 02;10:168
pubmed: 19486540
Trends Pharmacol Sci. 2015 Nov;36(11):724-736
pubmed: 26538314
Chem Biol Drug Des. 2010 Sep 1;76(3):201-17
pubmed: 20626410
J Med Chem. 2015 Aug 27;58(16):6653-64
pubmed: 26225459
Science. 2013 Sep 20;341(6152):1387-90
pubmed: 24030490
Nature. 2015 Apr 16;520(7547):317-21
pubmed: 25822790
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:19-37
pubmed: 27959623
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Nature. 2013 Dec 5;504(7478):101-6
pubmed: 24256733
Nat Struct Biol. 2002 Apr;9(4):268-72
pubmed: 11896401
Nature. 2018 Jan 3;553(7686):111-114
pubmed: 29300009
Nat Protoc. 2015 May;10(5):733-55
pubmed: 25855957
Nature. 2014 Sep 4;513(7516):124-7
pubmed: 25043059
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
Science. 2007 Nov 23;318(5854):1258-65
pubmed: 17962520
Nat Struct Mol Biol. 2017 Jul;24(7):570-577
pubmed: 28581512
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W582-9
pubmed: 20478829
Bioinformatics. 2013 Sep 15;29(18):2357-9
pubmed: 23842804
J Med Chem. 2007 Mar 22;50(6):1231-40
pubmed: 17305325
J Med Chem. 2019 Jan 10;62(1):207-222
pubmed: 29455526
Trends Pharmacol Sci. 2017 Sep;38(9):837-847
pubmed: 28648526
Nature. 2017 May 4;545(7652):112-115
pubmed: 28445455
Chem Biol Drug Des. 2014 Feb;83(2):237-46
pubmed: 24112716
J Am Chem Soc. 2013 Apr 24;135(16):6242-56
pubmed: 23506214
Neuropharmacology. 2011 Jan;60(1):36-44
pubmed: 20624408
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4290-5
pubmed: 11904374
Antimicrob Agents Chemother. 2005 Nov;49(11):4721-32
pubmed: 16251317
J Mol Biol. 2011 Nov 4;413(4):773-89
pubmed: 21945529
FEBS Lett. 2009 Jun 5;583(11):1692-8
pubmed: 19303011
J Med Chem. 1985 Jul;28(7):849-57
pubmed: 3892003
Bioorg Med Chem Lett. 2017 Jun 1;27(11):2239-2258
pubmed: 28408223
Nature. 2017 Aug 24;548(7668):480-484
pubmed: 28813418
Curr Opin Struct Biol. 2004 Dec;14(6):706-15
pubmed: 15582395
Structure. 2017 Mar 7;25(3):546-558
pubmed: 28190781
J Med Chem. 2015 Dec 10;58(23):9063-88
pubmed: 26230724
Bioinformatics. 2009 Mar 1;25(5):621-7
pubmed: 19176554
Bioinformatics. 2012 Jan 15;28(2):286-7
pubmed: 22113084
Methods Mol Biol. 2012;819:3-12
pubmed: 22183526
Chem Biol Drug Des. 2018 Jan;91(1):5-16
pubmed: 28639411
Nat Rev Drug Discov. 2019 Jan;18(1):59-82
pubmed: 30410121
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
J Biol Chem. 2009 Sep 18;284(38):26063-9
pubmed: 19581639
J Chem Inf Model. 2012 Jan 23;52(1):120-33
pubmed: 22087639
Curr Opin Struct Biol. 2002 Feb;12(1):14-20
pubmed: 11839484
BMC Struct Biol. 2006 Sep 24;6:19
pubmed: 16995956
J Comput Aided Mol Des. 2009 Aug;23(8):491-500
pubmed: 19521672
Nature. 2016 Apr 25;533(7602):274-7
pubmed: 27111510

Auteurs

Amanda E Wakefield (AE)

Department of Chemistry, Boston University, Boston, MA, 02215, USA.
Department of Biomedical Engineering, Boston University, Boston, MA, 02215, USA.

Jonathan S Mason (JS)

Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG, UK.

Sandor Vajda (S)

Department of Chemistry, Boston University, Boston, MA, 02215, USA. vajda@bu.edu.
Department of Biomedical Engineering, Boston University, Boston, MA, 02215, USA. vajda@bu.edu.

György M Keserű (GM)

Medicinal Chemistry Research Group, Research Center for Natural Sciences, Magyar tudósok krt. 2, H-1117, Budapest, Hungary. gy.keseru@ttk.mta.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH